NEXGEL (NXGL) CEO Adam Levy sells 6,000 common shares but keeps large stake
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NEXGEL, INC. Chief Executive Officer Adam R. Levy reported open-market sales of company common stock. He sold 3,000 shares at $0.5936 per share on June 4 and 3,000 shares at $0.5470 per share on June 8. After these transactions, he directly holds 336,692 shares of NEXGEL common stock, indicating he retained the vast majority of his position.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 6,000 shares ($3,422)
Net Sell
2 txns
Insider
Levy Adam R.
Role
Chief Executive Officer
Sold
6,000 shs ($3K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,000 | $0.547 | $2K |
| Sale | Common Stock | 3,000 | $0.5936 | $2K |
Holdings After Transaction:
Common Stock — 336,692 shares (Direct, null)
Footnotes (1)
- The Reporting Person sold all 3,000 shares of common stock in the open market at a price of $0.5936 per share. The Reporting Person sold all 3,000 shares of common stock in the open market at a price of $0.5470 per share.
Key Figures
Shares sold June 4: 3,000 shares at $0.5936
Shares sold June 8: 3,000 shares at $0.5470
Total shares sold: 6,000 shares
+2 more
5 metrics
Shares sold June 4
3,000 shares at $0.5936
Open-market sale of NEXGEL common stock
Shares sold June 8
3,000 shares at $0.5470
Open-market sale of NEXGEL common stock
Total shares sold
6,000 shares
Two non-derivative open-market sales
Shares held after transactions
336,692 shares
Direct ownership of NEXGEL common stock
Net buy/sell direction
Net sale of 6,000 shares
Form 4 transaction summary
Key Terms
open-market sale, non-derivative, Common Stock
3 terms
open-market sale financial
"The Reporting Person sold all 3,000 shares of common stock in the open market at a price of $0.5936 per share."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
non-derivative financial
"transaction_type": "non-derivative""
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transactions did NEXGEL (NXGL) report for CEO Adam R. Levy?
NEXGEL reported that CEO Adam R. Levy sold a total of 6,000 shares of common stock in two open-market transactions. These non-derivative sales were disclosed on a Form 4 and involved small portions of his overall direct holdings.
What are Adam R. Levy’s NEXGEL (NXGL) holdings after the reported sales?
Following the two open-market sales totaling 6,000 shares, Adam R. Levy directly holds 336,692 shares of NEXGEL common stock. This shows that, despite the sales, he maintains a substantial remaining equity position in the company.
Were the recent NEXGEL (NXGL) CEO transactions derivative exercises or simple stock sales?
The reported NEXGEL CEO transactions were simple stock sales, not derivative exercises. Both entries involve non-derivative common stock, coded as open-market sales, with no associated option exercise or conversion prices disclosed in the Form 4 data.
Do the NEXGEL (NXGL) CEO’s Form 4 footnotes change how the sales are interpreted?
The footnotes confirm that Adam R. Levy himself sold all 3,000 shares in each transaction at the stated prices in the open market. They do not reference trusts, LLCs, or lack of voting power, so the sales are attributed directly to him.